TF and cancer: A total of 47.62% of cancers that highly expressed the top-ranked five TFs of scSTAR-TF-C1 had significantly better OS, while only 28.57% of cancers had significantly better OS predicted by the top-ranked five TFs of scSTAR-TF-C2.